Skip Nav Destination
Drug Discovery
Antiviral Discovery for Highly Pathogenic Emerging Viruses
Edited by
César Muñoz-Fontela;
César Muñoz-Fontela
Bernhard Nocht Institute for Tropical Medicine, Germany
Search for other works by this author on:
Rafael Delgado
Rafael Delgado
Hospital Universitario 12 de Octubre, Madrid, Spain
Search for other works by this author on:
Hardback ISBN:
978-1-78801-564-6
PDF ISBN:
978-1-78801-685-8
EPUB ISBN:
978-1-83916-053-0
Special Collection:
2021 ebook collection
Series:
Drug Discovery
No. of Pages:
290
Publication date:
26 Nov 2021
Book Chapter
Chapter 5: Antiviral Strategies for Ebola Virus and Other Filoviruses: Antibodies
By
Larry Zeitlin
;
Larry Zeitlin
Mapp Biopharmaceutical, Inc.
4921 Directors Place Suite 100
San Diego
CA 92121
USA
larry.zeitlin@mappbio.com
Search for other works by this author on:
Marc-Antoine de La Vega
;
Marc-Antoine de La Vega
Université Laval, Département de microbiologie-infectiologie et d'immunologie, Faculté de médecine
2325, Rue de l'Université
Québec City (Québec) G1V 0A6
Canada
gary.pignac-kobinger.1@ulaval.ca
Search for other works by this author on:
Andrew Hiatt
;
Andrew Hiatt
Mapp Biopharmaceutical, Inc.
4921 Directors Place Suite 100
San Diego
CA 92121
USA
larry.zeitlin@mappbio.com
Search for other works by this author on:
Gary Kobinger
Gary Kobinger
Université Laval, Département de microbiologie-infectiologie et d'immunologie, Faculté de médecine
2325, Rue de l'Université
Québec City (Québec) G1V 0A6
Canada
gary.pignac-kobinger.1@ulaval.ca
Search for other works by this author on:
-
Published:26 Nov 2021
-
Special Collection: 2021 ebook collectionSeries: Drug Discovery
Citation
Larry Zeitlin, Marc-Antoine de La Vega, Andrew Hiatt, Gary Kobinger, 2021. "Antiviral Strategies for Ebola Virus and Other Filoviruses: Antibodies", Antiviral Discovery for Highly Pathogenic Emerging Viruses, César Muñoz-Fontela, Rafael Delgado
Download citation file:
Antibodies play a critical role in the prevention and resolution of infectious diseases. This chapter focuses on the role of antibodies in filovirus infection and disease. Anti-filovirus antibodies are critical in overcoming filovirus infections as well as in the activity of experimental vaccines. Additionally, antibodies, specifically monoclonal antibodies, show great promise as therapeutic medical countermeasures for filovirus infection.
You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Digital access
$64.60
